George Tsey Sabblah
Overview
Explore the profile of George Tsey Sabblah including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
25
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nambasa V, Gunter H, Adeyemo M, Bhawaneedin N, Blockman M, Sabblah G, et al.
Drug Saf
. 2025 Jan;
48(3):233-249.
PMID: 39843797
Introduction: The COVID-19 pandemic accelerated new vaccine development. Limited safety data necessitated robust global safety surveillance to accurately identify and promptly communicate potential safety issues. The African Union Smart Safety...
2.
Darko D, Seaneke S, Karikari-Boateng E, Nkansah E, Amponsa-Achiano K, Mohamed N, et al.
Vaccine
. 2024 Oct;
42(26):126460.
PMID: 39447252
Introduction: The development of COVID-19 vaccines during the pandemic occurred with an unprecedented speed, requiring extraordinary post-approval safety monitoring to facilitate ongoing evaluation of their benefit-risk profile. In Ghana, the...
3.
Sabblah G, Taxis K, Duwiejua M, Seaneke S, van Puijenbroek E, van Hunsel F
Expert Opin Drug Saf
. 2024 Oct;
23(12):1493-1501.
PMID: 39400306
Introduction: Patient engagement in pharmacovigilance (PEP) has been shown to improve information on adverse drug reactions (ADRs), which may not be found in reports from healthcare professionals. This review shows...
4.
Asare A, Sabblah G, Buabeng R, Alhassan Y, Asamoa-Amoakohene A, Amponsa-Achiano K, et al.
PLOS Glob Public Health
. 2024 Sep;
4(9):e0003770.
PMID: 39331603
Vaccines are important public health tools and formed part of the fight against the COVID-19 pandemic. Five COVID-19 vaccines were given Emergency Use Authorization in Ghana and deployed during the...
5.
Sabblah G, van Hunsel F, Taxis K, Duwiejua M, Seaneke S, van Puijenbroek E
Ther Adv Drug Saf
. 2024 Jan;
15:20420986231225850.
PMID: 38293565
Background: Medication errors (MEs) by caregivers at home are a cause of morbidity and mortality, shortly after discharge from the hospital. Objectives: The objective of this study was to determine...
6.
Mukonzo J, Ndagije H, Sabblah G, Mathenge W, Price D, Grasela T
Clin Transl Sci
. 2023 Nov;
17(1):e13683.
PMID: 37957894
Drug regulatory institutions, infrastructures, and systems are becoming increasingly interconnected across national boundaries and increasingly global in outlook. This process is reflected in the broadening and deepening application of the...
7.
Seaneke S, Darko D, Nkansah E, Asamoa-Amoakohene A, Ashie A, Sampson Ewudzie J, et al.
Digit Health
. 2023 Nov;
9:20552076231211276.
PMID: 37936957
Background: The use of mobile phone technology for reporting adverse drug reactions (ADRs) in pharmacovigilance is relatively new.The objective of the study was to explore challenges and facilitators for the...
8.
Buabeng R, Dsane-Aidoo P, Asamoah Y, Bandoh D, Boahen Y, Sabblah G, et al.
PLoS One
. 2023 Sep;
18(9):e0291482.
PMID: 37699058
Background: Adverse Drug Reactions (ADRs) can occur with all medicines even after successful extensive clinical trials. ADRs result in more than 10% of hospital admissions worldwide. In Ghana, there has...
9.
Sabblah G, Seaneke S, Kushitor M, van Hunsel F, Taxis K, Duwiejua M, et al.
PLoS One
. 2022 Mar;
17(3):e0264699.
PMID: 35239736
Background: Reviewing the epidemiological profile of medication errors (MEs) reported by African countries and the systems put in place to report such errors is crucial because reporting plays an important...
10.
Patient preferences and expectation for feedback on adverse drug reaction reports submitted in Ghana
Sabblah G, Darko D, Harmark L, van Puijenbroek E
Ghana Med J
. 2019 Sep;
53(2):150-155.
PMID: 31481811
Background: Personalized feedback received for spontaneous adverse drug reaction (ADR) reports serves as motivation for future reporting and the effectiveness of the feedback is dependent on the medium used in...